E J Schaefer
Overview
Explore the profile of E J Schaefer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
338
Citations
6799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schaefer E, Brousseau M
Prev Cardiol
. 2002 Feb;
3(3):136-139.
PMID: 11834931
No abstract available.
12.
Galluzzi J, Cupples L, Otvos J, Wilson P, Schaefer E, Ordovas J
Atherosclerosis
. 2001 Dec;
159(2):417-24.
PMID: 11730822
We investigated the potential role of the genetic variation at the intestinal fatty acid binding protein gene (FABP2) in influencing lipid levels in a representative sample of the Framingham Offspring...
13.
Schaefer E, Audelin M, McNamara J, Shah P, Tayler T, Daly J, et al.
Am J Cardiol
. 2001 Nov;
88(10):1129-33.
PMID: 11703957
Plasma lipoprotein levels, including remnant-like particle (RLP) cholesterol and RLP triglycerides, were assessed in fasting (12 hours) and postprandial (PP) (4 hours after a fat-rich meal) states in 88 patients...
14.
Schaefer E, Brousseau M, Diffenderfer M, Cohn J, Welty F, Oconnor Jr J, et al.
Atherosclerosis
. 2001 Nov;
159(1):231-6.
PMID: 11689226
Tangier disease (TD), caused by mutations in the gene encoding ATP-binding cassette 1 (ABCA1), is a rare genetic disorder in which homozygotes have a marked deficiency of high density lipoproteins...
15.
Sun Z, Welty F, Dolnikowski G, Lichtenstein A, Schaefer E
Am J Clin Nutr
. 2001 Aug;
74(3):308-14.
PMID: 11522553
Background: Apolipoprotein (apo) A-IV is a major component of triacylglycerol-rich lipoprotein (TRL) apolipoproteins. Objective: We investigated the effects of dietary saturated fat and cholesterol restriction on the metabolism of TRL...
16.
Pedro-Botet J, Schaefer E, Black D, Stein E, Corella D, Ordovas J
Atherosclerosis
. 2001 Aug;
158(1):183-93.
PMID: 11500190
The response to therapy with hypolipidemic agents shows considerable individual variation. These differences may be due to the interaction of environmental and genetic factors that affect drug bioavailability, receptor function...
17.
Russo G, Meigs J, Cupples L, Demissie S, Otvos J, Wilson P, et al.
Atherosclerosis
. 2001 Aug;
158(1):173-81.
PMID: 11500189
Apolipoprotein (apo) CIII participates in the regulation of the metabolism of triglyceride-rich lipoproteins and it is a major component of chylomicrons and VLDL. The APOC3 gene is on chromosome 11q23...
18.
Brousseau M, Schaefer E
Curr Atheroscler Rep
. 2001 Aug;
3(5):365-72.
PMID: 11487447
Epidemiologic studies have established that a low concentration of plasma high-density lipoprotein (HDL) cholesterol is an independent risk factor for coronary heart disease (CHD). In the United States, a low...
19.
McKenney J, McCormick L, Schaefer E, Black D, WATKINS M
Am J Cardiol
. 2001 Jul;
88(3):270-4.
PMID: 11472706
This study was conducted to determine the efficacy of atorvastatin and niacin on lipoprotein subfractions in patients with atherogenic dyslipidemia. This was a multicenter, randomized, open-label, parallel-design study of patients...
20.
Lyu L, Yeh C, Lichtenstein A, Li Z, Ordovas J, Schaefer E
Am J Clin Nutr
. 2001 Jul;
74(1):64-71.
PMID: 11451719
Background: There is limited information regarding the associations of lifestyle factors and sex with HDL subclasses containing apolipoprotein (apo) A-I (Lp A-I) and both apo A-I and apo A-II (Lp...